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THE REGULATION OF LIPID METABOLISM in vertebrates is a complex process and has become an extensive field of research in aquaculture because of its relevance throughout fish life, from the egg survival phase to the reproduction stage. Fatty acids (FAs) have a variety of functions in fish (71) . They form part of the biological membranes, contribute to the synthesis of eicosanoids, and can act as transcriptional regulators of genes involved in lipid metabolism and other functions (38) . FAs can either be oxidized to obtain energy or stored as triacylglycerols (TAG). In trout, as in other salmonids, the main tissues involved in FA oxidation are liver, heart, and red and white muscle (6) . However, the capacity to oxidize FAs varies with the tissue (28, 50) . Thus, white muscle shows low oxidative activity per milligram of protein compared with other tissues such as red muscle, but the oxidative contribution of this tissue in relation to the fish weight is the highest, since a high percentage of the body mass of salmonids is white muscle (68) .
The oxidative capacity varies depending on fish size, life stage and season (69) . Furthermore, salmonid white muscle has a high capacity to store lipids (27) , mostly in the myosepta, where intramuscular adipose cells are located. For these reasons, muscle is one of the main lipid reserve tissues, together with visceral fat and liver. Given the inclusion of fish in our diets, the quantity and quality of lipids in the flesh are crucial to human health.
Despite the importance of lipid metabolism in fish muscle, the regulation of FA ␤-oxidation and lipid storage in fish muscle is not well known. Several studies on these processes have been conducted in trout and salmon, mostly analyzing the effects of dietary fat origin (70, 72) . Nevertheless, few studies on the hormonal regulation of lipid metabolism in fish have been reported. Insulin and insulin-like growth factor I (IGF-I) are among the main regulators of fish metabolism (51) . Insulin injections in fish reduce the levels of plasma free FA (3, 60) and have an antilipolytic effect on liver and adipose tissue pieces (30, 31) and isolated adipocytes (1, 2) . The enzyme lipoprotein lipase (LPL), a key regulator of lipid homeostasis, is regulated by insulin in the adipose tissue of rainbow trout, but not in muscle (4) . Moreover, insulin acute and chronic administrations in rainbow trout altered the mRNA expression of other key enzymes for the lipid metabolism, increasing the FA synthase and decreasing some isoforms of carnitine palmitoyltransferase 1 (CPT-1) (60) . The effects of catecholamines, specifically adrenalin (ADR) and noradrenalin (NA), on lipid mobilization have been tested in several fish species (75), although results are contradictory when different models are used (24, 37) . Some reports support the antilipolytic effects of catecholamines, especially for NA in fish. This is in contrast to mammalian findings (47, 78) . Nevertheless, information on the direct effect of hormones on lipid metabolism in fish muscle is scarce.
Although several studies reveal that fish are intolerant to high levels of glucose in their diet (15) and some of the enzymatic pathways have been analyzed, no study has addressed the regulation of the metabolic fate of glucose in fish myotubes in an attempt to achieve a better understanding of, or even improve, glucose utilization in fish muscle. The few studies available on fish glucose metabolism are focused on glucose distribution in tissues after food intake (32) . Furthermore, insulin increases glucose incorporation into catfish muscle in vivo (45) and glucose uptake in cultured myocytes from rainbow trout (11) . In this line, it has been recently described that in vivo insulin treatment increased the glycogen content in the muscle of rainbow trout through upregulating the glycogen synthetase activity (61) . IGF-I was more effective than insulin in increasing glucose transport into fish myocytes and myotubes (11, 13), but no information regarding the effect of these hormones in glucose oxidation and glycogen accumulation is available.
A number of drugs are reported to regulate lipid and glucose metabolic pathways in mammals. TOR (target of rapamycin) is involved in the insulin and IGF-I receptor signaling pathway. The effect of rapamycin, a TOR inhibitor, has been evaluated in mammalian muscle cell lines. This drug leads to reduced glucose oxidation but increased FA utilization (66) . Etomoxir, an irreversible inhibitor of CPT-1, prevents FAs from entering mitochondria, thereby provoking not only the inhibition of FA oxidation (40) but also intramyocellular lipid accumulation and increased glucose utilization in rats (20, 22) . The thiazolidinedione rosiglitazone (BRL49653) is a peroxisome proliferator-activated receptor ␥ (PPAR␥) agonist that, by modifying the transcription of several key enzymes, reduces the insulin resistance that affects lipid and glucose metabolism (48, 79) . To our knowledge, the metabolic actions of these factors in fish muscle metabolism have not been reported.
Considering the relatively high capacity of salmonid muscle to oxidize and store lipids, and taking into account the information currently available on hormonal regulation of lipid metabolism in fish, we hypothesize that FA oxidation and deposition in rainbow trout muscle will be closely regulated by insulin, IGF-I, and catecholamines. We chose the oleic acid as representative FA mainly because its abundance in fish feed these days. Thus, the objective of this study was to assess the anabolic or catabolic effect of insulin, IGF-I, and catecholamines (ADR and NA) on oleic acid metabolism and to compare them with the effects on glucose metabolism using differentiated myotubes in a primary culture of rainbow trout. Furthermore, we used various drugs, including rapamycin, etomoxir, and rosiglitazone, to gain a greater understanding of the mechanisms involved in the regulation of oleic acid and glucose metabolism.
MATERIALS AND METHODS

Animals
Rainbow trout (Oncorhynchus mykiss; Walbaum, 1792) were obtained from the fish farm "Truites del Segre" (Lleida, Spain) and acclimated to laboratory conditions in the Faculty of Biology facilities at the University of Barcelona, in a closed-water flow system at a constant temperature of 14 Ϯ 1°C and acclimated for 15 days before any experiments were conducted. The animals were maintained on a 12:12-h light-dark cycle. They were fed ad libitum by hand once a day and fasted for 24 h before the culture procedure. All animal-handling procedures (Catalan government registration number 4205) were approved by the Ethics and Animal Care Committee of the University of Barcelona, following the legislation and procedures established by the European Union and by the Spanish and Catalan governments.
Cell Culture Procedure
Cells were isolated, pooled, and cultured, as described previously (12, 62) . Briefly, fish weighing around 10 g were killed by a blow to the head and immersed in 70% ethanol to sterilize the external surfaces. White myotomal muscle was excised under sterile conditions and subsequently digested with collagenase type Ia at 0.2% wt/vol and trypsin at 0.1% wt/vol. Satellite cells were recovered by centrifugation and seeded in 25-cm 2 Nunclon flasks pretreated with poly-L-lysine MW 70,000 -150,000. Cells were maintained at 18°C in DMEM high glucose plus 10% FBS and antibiotics (growth medium) until day 11 (myotube stage) (12) , when all the experiments were carried out.
CPT-1 Activity
Three rainbow trout of around 200 g were killed by a blow to the head, and samples from the white epaxial muscle, behind the dorsal fin, were taken. CPT-1 activity was performed as described by Morash et al. (50) . Isolated mitochondria preparations were preincubated for 5 min with malonyl-CoA (50 M) or etomoxir (10 M) prior to the addition of the reaction mix.
CPT-1b mRNA Expression in Rainbow Trout Myotubes
The mRNA expression of CPT-1b was evaluated in rainbow trout myotubes (day 11). The cells (day 11, myotube stage) were starved for 4 h and then treated with insulin (1,000 nM) for 3, 6, and 18 h or with oleic acid (100 M) for 24 h. Total RNA was extracted by the TriReagent method in accordance with the manufacturer's instructions. The quantity and quality of isolated RNA were determined by spectrophotometry with the Nanodrop ND-1000 (Labtech International, East Sussex, UK). For cDNA synthesis, 1 g of RNA, 3 l of a 2:1 blend of random hexamers (600 M)/oligo dT (50 M), 2 l dNTP (10 mM), 0.5 l of reverse transcriptase (20 U/l), and 0.5 l of RNAse inhibitor (40 U/l) were mixed with the kit buffer in a final volume of 20 l (Transcriptor first-strand cDNA synthesis kit), and incubated at 50°C for 60 min, followed by the inactivation of the enzymes at 85°C for 5 min. PCR measurements were performed by applying the primers at 0.5 M with one-fortieth of the cDNA synthesis reaction and SYBR-Green PCR mix in a total volume of 20 l. Primer sequences for CPT-1b were forward: 5=-CCCTAAG-CAAAAAGGGTCTTC and reverse: 5=-CATGATGTCACTCCCGA-CAG. Reactions were performed in an iQCycler iQ real-time detection system (Bio-Rad, Madrid, Spain). Each PCR product was sequenced to confirm identity, and each one was found to be 100% identical to its respective sequence. Two-fold serial dilutions of total RNA were made for efficiency calculations, resulting in a efficiency of 1.95. Reactions were performed in duplicate, and the fluorescence data acquired during the extension phase were normalized to eF1␣ (forward: 5=-TCCTCTTGGTCGTTTCGCTG and reverse: 5=-AC-CCGAGGGACATCCTGTG) by the delta-delta method (42) .
Incubations with Radiolabeled Substrates
Radiolabeled oleic acid incubations were carried out as described by Vegusdal et al. (77) . Myotube-stage cells were washed twice with serum-free growth medium and incubated in serum-free growth medium containing [1- 14 C]-oleic acid at 1 Ci/ml and 20 M of total oleic acid concentration. Oleic acid in its sodium salt form was added to the cells bound to BSA-free FA at an oleic acid to BSA-free FA ratio of 2.7:1. For the D-[U-
14 C] glucose incubations, low-glucose DMEM (1 g/l) was used for washes and for incubation with 1 Ci/ml of D-[U-
14 C] glucose. Oleic acid and glucose were incubated at 18°C for 48 h. To assess the effects of hormones, drugs, and glucose, these molecules were added to the cells at the concentration indicated at the same time as the medium containing the labeled substrate.
Measurements of [ 14 C]-CO2 and [ 14 C]-ASP Production
To quantify total oxidation of oleic acid and glucose (production of CO2) after each of the treatments, 1.5 ml of medium from trout myotubes was incubated with 300 l of 1 M HClO4 at 37°C in a vial sealed with a septum stopper containing a Whatman filter paper moistened with 300 l of phenylethylamine/methanol (1:1, vol/vol) under continuous shaking. The Whatman filter paper was removed after 1 h of incubation and placed in a scintillation vial with 5 ml of scintillation cocktail (EcoLite), and the radioactivity was counted in a TRICARB 2100 ␤-counter (Packard Bioscience, Meriden, CT). Acidsoluble products (ASP) were determined by incubating a mixture of cell medium and ice-cold 2 M HClO 4 at a ratio of 2:1 for 1 h at 4°C with continuous shaking. After centrifuging them, we used an aliquot of the supernatant for scintillation counting.
Lipid Extraction and Analysis of [ 14 C]-Lipid Classes
Total lipids were extracted from cells and from 2.5 ml of medium using the method described by Folch et al. (25) . The resulting chloroform phase was dried using a speedvac (Jouan RC10.09 coupled with RCT90 cold trap), and the resulting extract was dissolved in hexane. All extract recovered from cells or from medium from a single flask was separated by high-performance thin-layer chromatography (HPTLC) using a silicagel 60 plate and a mixture of petroleum ether, diethyl ether, and acetic acid (113:20:2, vol/vol/vol) as a mobile phase (77) . Lipid classes containing 14 C were visualized by overnight exposure of a Kodak medical X-ray film to the silica plates. Spot identification was carried out by comparison with known standards. Spots of free fatty acids (FFA), diacylglycerols (DAG) and TAG from cells and spots of FFA and DAG from media were scraped into scintillation vials and counted.
Determination of Glycogen Synthesis from Cells Incubated with D-[U-14 C] Glucose
A portion of the cellular extract was digested at 95°C for 30 min in the presence of NaOH 1 M. Glycogen precipitation was performed by adding 3 mg of cold glycogen and absolute ethanol and incubating this mixture at 4°C overnight, with continuous shaking. After a centrifugation (13000 g, 20 min, 4°C) and washing in ethanol 70%, the pellet was dissolved in water, and an aliquot was collected for scintillation counting.
Western Blot Analysis
Myotube cells on day 11 of differentiation were starved for 4 h. After this, they were prestimulated with inhibitors (wortmannin, 1,000 nM) and rapamycin (100 nM) for 30 min when necessary, and then with insulin (1,000 nM) or IGF-I (100 nM) for 30 additional min. Control cells were treated with medium without inhibitors and peptides. After this, cells were washed twice with ice-cold PBS and lysed with ice-cold lysis buffer (1% NP-40, 10 mM Tris, 140 mM NaCl, 5 mM EDTA, pH 7.6) containing a protease inhibitor cocktail (at a 1/200 dilution) and phosphatase inhibitors (50 mM NaF and 0.4 mM sodium orthovanadate). Thirty micrograms of protein was loaded in a 12% polyacrylamide gel to perform electrophoresis (SDS-PAGE). PVDF membranes were incubated overnight at 4°C with antibodies for either Akt, TOR, and their phosphorylated form: anti-pTOR (cat. no. 2971), anti-Akt (cat. no. 9272), anti-pAkt (cat. no. 9271; Cell Signaling Technology, Beverly, MA), and anti-TOR (cat. no. T2949; Sigma-Aldrich, Alcobendas, Spain) at 1:1,000 dilution. Secondary antibodies linked to HRP were added for 1 h at room temperature, and immunoreactive bands were visualized by ECL and quantified with an image analyzer (TotalLab v1.00, Nonlinear Dynamics, Durham, NC).
Materials and Chemicals
Nunclon culture flasks were purchased from NUNC (Roskilde, Germany). The human-IGF-I was purchased from Bachem (Bubendorf, Switzerland). The no. CFB.96) were purchased from Amersham Bioscience (Piscataway, NJ). All materials and reagents for lipid extraction and HPTLC performance were purchased from Merck (Darmstadt, Germany). The Kodak medical X-ray films were obtained from Kodak Industrie (Chalon sur Saone, France). The EcoLite scintillation cocktail was obtained from ICN Biomedicals (Irvine, CA). The rosiglitazone (BRL49653) was kindly donated by GlaxoSmithKline (Stevenage, UK). The TriReagent was obtained from Ambion, Applied Biosystems (Madrid, Spain). The transcriptor firststrand cDNA synthesis kit was purchased from Roche Diagnostics (Mannheim, Germany). The SYBR-Green PCR mix was from BioRad (Madrid, Spain). All other reagents were from Sigma-Aldrich Química (Alcobendas, Spain).
Statistical Analysis
Each cell treatment was performed in triplicate, each one from a separate cell culture. For recovery data, n ϭ 10 was used in the case of oleic acid metabolism (using data from all of the different experiments), and n ϭ 4 was used for the glucose distribution. For the CPT1 activity measurements, 3 different fish were used. Data were log-transformed to ensure normality of the data. Data in the figures are expressed as means ϩ SE. Statistical differences between conditions were analyzed in log-transformed data by t-test or by one-way ANOVA, followed by the Tukey test using the SigmaStat software ver. 3.10. Differences were considered statistically significant at P Ͻ 0.05.
RESULTS
Oleic Acid Metabolism
Distribution in lipid classes and oxidation products. The radioactivity recovery from radiolabeled oleic acid after 2 days of incubation of trout myotube cells was 89.0% Ϯ 6.4 of the initial value. The distribution of this radioactivity between the different lipid classes, CO 2 , and ASP in myotubes and incubation media are shown in Table 1 . The main part of the radioactivity was recovered in the lipid compartment, mostly as cellular lipids (61.5% Ϯ 4.8 of the recovered radioactivity). Only around 8.5% of the final radioactivity was recovered in an oxidized form (CO 2 or ASP).
Effects on CO 2 production. Insulin reduced the oxidation of oleic acid, measured as CO 2 production, of trout myotubes in a dose-response manner (10, 100, and 1,000 nM) with a significant decrease at 1,000 nM (Fig. 1A) . In contrast, IGF-I, used at 10 and 100 nM, was more potent than insulin at reducing CO 2 production, and a significant effect was already observed at 100 nM and quantitatively similar to that found after incubation with insulin at 1,000 nM. Insulin also reduced the mRNA expression of CPT-1b in trout myotubes (P Ͻ 0.05), while incubating them with oleic acid significantly increased the CPT-1b mRNA expression by ϳ5.5-fold the control values ( Fig. 2A) .
To check whether rapamycin is able to inhibit TOR in our cell culture, we tested the rapamycin action on TOR activation using Western blot analysis. Rapamycin (100 nM) suppressed the activation of TOR provoked by insulin and IGF-I stimulation (P Ͻ 0.05) (Fig. 3B) . Furthermore, wortmannin significantly inhibited the activation of Akt by insulin and IGF-I (Fig.  3A) . The incubation with rapamycin (100 nM) significantly To calculate the recovery values, data from control cells of all the experiments were used. Values are expressed as means Ϯ SE (n ϭ 10).
increased the CO 2 content in the medium of the rainbow trout myotubes (Fig. 4A) .
The addition of rosiglitazone at 10 M reduced CO 2 production by rainbow trout myotubes (P Ͻ 0.05) (Fig. 4A) .
Etomoxir and malonyl-CoA were effective at reducing the CPT-1 activity in isolated white muscle mitochondria in rainbow trout (P Ͻ 0.05) (Fig. 2B) . Etomoxir also significantly decreased CO 2 production, at 100 M, of rainbow trout myotubes in culture (Fig. 4A) .
Incubation with ADR or NA, both at 10 M, had no significant effect on CO 2 production, while an increase in glucose concentration in the medium produced a significant reduction in CO 2 production ( Table 2) .
Effects on ASP production. Levels of labeled ASP decreased significantly with respect to the control values using IGF-I at both 10 and 100 nM, with the latter concentration having a stronger effect (Fig. 1B) . Insulin followed the same tendency as IGF-I, but no significant decrease was observed at any particular concentration.
Incubation of the rainbow trout myotubes with rapamycin produced a significant increase in ASP content (Fig. 4B) . Incubation with rosiglitazone led to a reduction of ASP levels (P Ͻ 0.05) (Fig. 4B) . Etomoxir, at 10 M, significantly decreased ASP formation, with a stronger effect observed at 100 M (Fig. 4B) . No significant effect on ASP production was produced by ADR, NA, or glucose (Table 2) .
Oleic acid distribution between lipid classes.
The results of the effects of insulin and IGF-I on the distribution of labeled oleic acid in the different lipid compartments studied are shown in Fig. 5 . IGF-I 100 nM significantly reduced FFA in the medium, while insulin showed similar reduction levels as IGF-I, although they were not significant with respect to the control values. The DAG levels in the medium decreased significantly in response to insulin, particularly at 1,000 nM. FFA levels in the cell fraction increased with IGF-I at 100 nM (P Ͻ 0.05). Finally, insulin and IGF-I increased cellular TAG, but the effects were not statistically significant at either peptide concentration.
Rapamycin increased FFA content in the medium, while it reduced cellular DAG and TAG (P Ͻ 0.05) (Fig. 6A) . Rosiglitazone significantly induced FFA in the medium; however, DAG decreased in response to this drug (P Ͻ 0.05). Cellular FFA content significantly increased after rosiglitazone stimulation. Nevertheless, DAG and TAG decreased with this agonist (P Ͻ 0.05) (Fig. 6B ). The addition of etomoxir (100 M) 14 C]-oleic acid of rainbow trout myotubes. Values are expressed as means Ϯ SE (n ϭ 3). Statistical differences were analyzed in log-transformed data. Treatment bars are relative to the control set to 1 (not shown). *Significant differences from control values.
a,b Significant difference is shown by letters that differ above bars (P Ͻ 0.05, ANOVA followed by the Tukey test).
produced a strong and significant increase in FFA in the medium. Etomoxir (100 M) significantly increased FFA and decreased TAG content in the cells (Fig. 6C) . No significant effect on FFA levels in the medium was produced by ADR, NA, or glucose; however, glucose (5 mM) reduced the presence of DAG in the cell medium (Table 2) . Glucose (5 mM) and ADR reduced FFA in the cellular fraction. Glucose (5 mM) also increased TAG content (P Ͻ 0.05). The catecholamines had no effect on cellular DAG or TAG levels.
Glucose Metabolism Distribution in glycogen and oxidation products. The percentage of radioactivity recovered after incubating trout myotubes with D-[U-
14 C] glucose for 2 days was 83.2% Ϯ 3.3. The radioactivity distribution between glycogen and oxidized products showed the following pattern: glycogen 0.01% Ϯ 0, CO 2 0.2% Ϯ 0.01, and in the ASP compartment, 99.8% Ϯ 0.01, of the total recovered radioactivity. There is no further mention of the latter compartment because it was impossible to distinguish the radioactive intermediate products from the initial radioactive glucose. No radioactivity was detected in the HPTLC plates holding the lipid extracts even after 1 wk of exposure of the X-ray films.
CO 2 production. Radioactive CO 2 levels did not change significantly in response to insulin and IGF-I (Fig. 7A) . No changes were observed after rapamycin, rosiglitazone, and etomoxir treatment (data not shown).
Glycogen synthesis. There was a significant increase in glycogen content in the cells treated with insulin at 100 and 1000 nM (Fig. 7B) . The effects of IGF-I were similar in magnitude to that of insulin, but no significant differences were found. No effect was detected after incubations with rapamycin, etomoxir, or rosiglitazone (data not shown).
DISCUSSION
The total radioactivity recovered from oleic acid and glucose after 2 days of incubation in our study was in the same range as that previously reported in similar experiments with salmon myotubes (77). Those authors described a 50% recovery from oleic acid as oxidized forms (CO 2 and ASP) and 18% as cell lipids. Nevertheless, in trout myotubes, 8.5% and 61.5% of the initial radioactivity was recovered as oxidized forms and as cell lipids, respectively. Given that the same incubation time and C]-oleic acid of rainbow trout myotubes. Values are expressed as means Ϯ SE (n ϭ 3). Statistical differences were analyzed in log-transformed data. Treatment bars are relative to the control set to 1 (not shown). *Significant differences from control values. a,b Significant difference is shown by letters that differ above bars (P Ͻ 0.05, t-test for rapamycin and rosiglitazone treatments; P Ͻ 0.05, ANOVA followed by the Tukey test for etomoxir treatments). oleic acid concentrations were used in both studies, it appears that trout myotubes may have the capacity to accumulate lipids more quickly and that their oxidative capacity may be lower than that of salmon myotubes. Nevertheless, the lipid content in salmon flesh is higher than in rainbow trout (23, 35) , with the majority located in the myosepta (83), while similar CPT-1 activity has been reported in white muscle of salmon and trout (28, 50 ). An in vitro approach reflects more clearly the capacity of the muscle cells of each species to store or oxidize lipids. However, the salmon study and our study are not strictly comparable, and differences in culture conditions, such as culture time, differentiation of the cells, and the incubation temperature, may be considerable, although cells reached the myotube stage in both studies.
Insulin is a proanabolic and anticatabolic hormone in fish that promotes the deposition of lipids (51) . For example, it regulates LPL activity and the lipolysis rate in gilthead sea bream and rainbow trout (1-4) . However, the endocrine control of lipid and glucose oxidation and the distribution in fish myotubes in culture have not been addressed to date. In our study, insulin and IGF-I significantly reduced the oxidation of oleic acid (measured as CO 2 production) by rainbow trout myotubes. This observation is consistent with findings in mammalian muscle cell lines and in muscle primary cultures (7, 9, 29, 58) . This insulin effect agrees with the inhibition of insulin on CPT-1b mRNA expression in trout myotubes. In the same line, a decrease in CPT-1b expression has been recently reported after chronic insulin treatment in rainbow trout muscle (60) . Insulin caused a significant decrease in CO 2 production at 1,000 nM, while IGF-I produced the same reduction at 100 nM in trout myotubes. This finding could be attributed to the predominance of IGF-I receptors over insulin receptors in fish Values are expressed as means Ϯ SE (n ϭ 3). Statistical differences were analyzed in log-transformed data. Treatment bars are relative to the control set to 1 (not shown). *Significant difference from control value (P Ͻ 0.05, t-test). Fig. 5 . Effects of INS (10, 100, and 1,000 nM) (A) and IGF-I (10 and 100 nM) (B) on distribution of radioactivity in cellular and medium lipids from [1- 14 C]-oleic acid of rainbow trout myotubes. Values are expressed as means Ϯ SE (n ϭ 3). Statistical differences were analyzed in log-transformed data. Treatment bars are relative to the control set to 1 (not shown). *Significant differences from control values. a,b Significant difference is shown by letters that differ above bars (P Ͻ 0.05, ANOVA followed by the Tukey test).
tissues, which is also observed in primary cultures of fish satellite cells and in skeletal muscle semipurified receptor preparations (12, 49, 56, 57) . IGF-I is more potent than insulin on glucose, alanine, and thymidine uptake by myocytes and myotubes of rainbow trout (11) . Incubating the rainbow trout myotubes with IGF-I significantly increased the FFA inside the cells and tended to increase the TAG content, and, moreover, IGF-I significantly decreased the FFA content in the medium. These observations are consistent with an increase in oleic acid uptake by myotubes and incorporation into TAG. Insulin stimulates TAG accumulation in mammals by inhibiting the hormone-sensitive lipase (34) and activating the diacylglycerol acyltransferase 1, the last enzyme of the glycerolphosphate synthesis pathway of TAG (14) . Both of these enzymes have been found in fish tissues (16, 53) . Insulin also increases FA uptake in cardiac and skeletal myocytes by stimulating FA transporter translocation to the plasma membrane (44, 81) . Knowledge of the insulin-sensitive FA transporters in fish is limited (33, 73, 74) . Consistent with the present results, we have recently observed that insulin regulates the expression of FATP1 and its translocation in salmon myotubes [in collaboration with B. E. Torstensen (NIFES, Norway) and B. Ruyter (NOFIMA, Norway); unpublished data].
Increasing the glucose concentration in the medium had some effects on oleic acid metabolism, such as a significant decrease in FA content, and there was an increase in TAG content inside the cells. This indicates that trout myotubes 14 C]-oleic acid of rainbow trout myotubes. Values are expressed as means Ϯ SE (n ϭ 3). Statistical differences were analyzed in log-transformed data. Treatment bars are relative to the control set to 1 (not shown). *Significant differences from control values.
a,b Significant difference is shown by letters that differ above bars (P Ͻ 0.05, t-test for rapamycin and rosiglitazone treatments; P Ͻ 0.05, ANOVA followed by the Tukey test for etomoxir treatments). FFA, free fatty acids; DAG, diacylglycerols; TAG, triacylglycerols. Fig. 7 . Effects of INS (10, 100, and 1,000 nM) and IGF-I (10 and 100 nM) on CO2 (A) and glycogen (B) production from D-[U-
14 C]-glucose of rainbow trout myotubes. Values are expressed as means Ϯ SE (n ϭ 3). Statistical differences were analyzed in log-transformed data. Treatment bars are relative to the control set to 1 (not shown). *Significant differences from control values. a,b Significant difference is shown by letters that differ above bars (P Ͻ 0.05, ANOVA followed by Tukey's test).
adapt their metabolism to substrate availability, in this case, by decreasing the energetic use of oleic acid in favor of the use of glucose when the latter is highly available. On the other hand, a significant increase in glycogen accumulation was observed after 2 days of incubation with insulin in our trout cell culture, using glucose as tracer, while no significant effects were found in CO 2 production. These findings are partially consistent with the effects reported in mouse cardiomyocytes (54, 55) , where both glycogen accumulation and CO 2 production increased after insulin treatment. In addition, insulin administration increased the glycogen content in rainbow trout muscle (61) . Overall, these results indicate that trout myotubes have a low capacity to regulate glucose utilization as an energy source in response to insulin and IGF-I compared with oleic acid. It is known that insulin and IGF-I increase glucose uptake in trout myoblast, although the dynamics of these processes differ from those in mammals (11, 21) , which helps to explain the lower capacity of fish to restore plasma glucose levels following a glucose load. Although the glycolytic and oxidative pathway seems not to have been activated by insulin in our system, glycogen synthesis was enhanced, showing that this hormone also has an anabolic role in glucose metabolism.
Insulin/IGF-I signaling pathways are similar in fish and mammals and can be inhibited by some of the same inhibitors (10) . The insulin/IGF-I signaling pathway member TOR (target of rapamycin) is reported to play a central role as a nutrient sensor in skeletal muscle, especially in protein metabolism (59) . TOR has recently been described in rainbow trout (64) and is activated in white muscle after a meal intake (64) . Recent findings indicate that TOR activation contributes to lipid metabolism regulation in mammals and also in trout (66, 67) . In the present study, we have shown that both insulin and IGF-I can activate the PI3K/Akt pathway by activating Akt and TOR. Moreover, wortmannin and rapamycin were found to be effective at inhibiting Akt and TOR, respectively. These results are consistent with previous data obtained by our group that showed that insulin and IGF-I activated both PI3K/Akt and MAPK signaling pathways in rainbow trout myocytes and myotubes (10, 13) . Besides, Polakof et al. (61) described Akt activation after in vivo insulin administration in rainbow trout muscle. Furthermore, we have observed that wortmannin and PD98059 inhibited the PI3K/Akt and MAPK signaling pathways, respectively (10, 13) . Very recently, the activation of TOR by insulin in rainbow trout hepatocytes has been described, as well as the fact that rapamycin can specifically inhibit this activation (36) . Along the same lines, we have observed that rapamycin is also effective at inhibiting TOR in myotubes of the same species. However, few studies have analyzed the effects of rapamycin on lipid and glucose metabolism in mammalian muscle cells, and no studies on fish have been reported. Trout myotubes showed a significant increase in oxidation of oleic acid after rapamycin stimulation, measured by increased production of CO 2 and ASP, which is consistent with previous studies in L6 cell line (66) . This effect could be mediated by increased CPT-1 activity (66) . A reduction in the TAG content inside the trout myotubes was observed in line with findings in rat hepatocytes (8) , while an increased FA proportion was present in the medium of the rapamycin-treated trout myotubes, which is consistent with a lower incorporation into TAG. These results support the notion that the TOR signaling pathway is involved in anabolic processes, such as FA incorporation into TAG and the reduction of oxidation; the effects of insulin and IGF-I might be mediated, at least partly, by this pathway. Glucose metabolism was rather insensitive to treatment with rapamycin, as shown by the absence of changes in glucose oxidation and glycogen production in rainbow trout myotubes after rapamycin treatment. However, this drug has been reported to decrease glucose utilization in L6 cells (66) .
CPT-1 activity, the initial and regulated step in the mitochondrial ␤-oxidation of FA, and subsequently the ␤-oxidation capacity, have been correlated with a number of natural and dietary factors in salmonids (28, 69) . Thus, to study how lipid metabolism works in conditions of low ␤-oxidation capacity, it is crucial to establish whether or not etomoxir is a good inhibitor of mitochondrial ␤-oxidation in our culture system. Acute etomoxir treatment in mammals irreversibly inhibits CPT-1, and extended incubation with this drug alters the expression of several metabolic enzymes associated with lipid metabolism (82) . In this study, we checked that etomoxir significantly inhibits the CPT-1 activity of the white muscle of rainbow trout. Moreover, etomoxir significantly inhibits CO 2 production of rainbow trout myotubes. This finding supports the notion that the contribution of peroxisomal ␤-oxidation is very low in skeletal muscle of salmonids (70) . Etomoxir prevented oleic acid from entering mitochondria, which resulted in a significant increase in extracellular and intracellular FA levels compared with the control. Etomoxir increases the FA transport inside the cell in the rat heart as compensation for the decrease in ␤-oxidation (52). This drug also increases the amount of lipids (as TAG) in rat muscle (22) , although we found an unexpected decrease of the TAG content in trout myotubes treated with etomoxir. Even though an increased glucose uptake and oxidation have been reported in rat myocytes after inhibition of FA oxidation (65), we did not observe any significant effects of etomoxir on glucose metabolism in our trout cell culture. These data indicate that etomoxir could be a useful tool for inhibiting ␤-oxidation in fish without apparently altering the glucose metabolism.
The PPAR isotypes (␣, ␤, and ␥) have been found in several fish species (17, 41, 63) ; however, their physiological function in teleosts is unclear, as there is evidence that PPARs could exert some opposing functions in fish and mammals (16) . PPAR␥ appears to be the key isotype involved in lipid deposition, at least in adipose tissue (73), although differences in structure and tissue expression distribution between fish and mammals have been reported (38) . Very recently, it has been reported that rosiglitazone, as a thiazolidinedione, binds and activates the PPAR␥ and activates the peroxisome proliferator response element of olive flounder after transfection in 3T3L1 adipocytes (18) . Unexpectedly, we observed that the incubation of the trout myotubes with rosiglitazone resulted in a reduction in the production of CO 2 and ASP from oleic acid. These findings contrast with reports in human and rat muscles, in which this drug produced an increase in FA oxidation (5, 80) . These effects in rainbow trout were accompanied by increased extracellular and intracellular FA, as a result of the reduction in oleic acid oxidation and TAG synthesis. The targets of PPAR␥ have not been as extensively studied in rainbow trout as in mammalian models. All piscine PPAR␥ proteins have a critical amino acid substitution, which according to some authors, may alter the capacity of synthetic ligands to activate fish PPAR␥ (39, 46) . Furthermore, a novel alterna-tive spliced form of PPAR␥ (PPAR␥ short) has been reported in adipocytes of Atlantic salmon (73) , but no information about the thiazolidinedione binding capacity is available. Further studies may elucidate the rosiglitazone action in trout PPAR␥ and in its target genes in fish.
Fish are usually exposed to a certain degree of stress, which could affect lipid metabolism. Stress induces several endocrine factors, but catecholamines (ADR and NA) are the only known hormones that affect the rate of lipolysis in the short term (76) . However, catecholamines show opposing actions or even have no effect in some fish models (19, 47, 78) . We have observed that neither ADR nor NA affected the oxidation of oleic acid, and only after ADR stimulation was there a significant decrease in FA inside the rainbow trout myotubes and slight nonsignificant increases in the FA outside the cells, which could be reminiscent of the lipolytic effect of catecholamines. Thus, despite the presence of a complete adrenergic receptor system in trout muscle (43) and the fact that ADR exerts glycolytic action in trout skeletal muscle (26) , the regulation of lipid metabolism by catecholamines does not appear to be relevant in trout myotubes in culture.
Here, we show, for the first time in fish, the anabolic effect of insulin and IGF-I on FA (oleic acid) metabolism in rainbow trout myotubes differentiated in culture. The metabolic effects of rosiglitazone, etomoxir, and rapamycin have not been assessed in fish muscle metabolism to date. These drugs exert a similar effect on the lipid metabolism of trout myotubes as in mammals, with the exception of rosiglitazone. In our culture, ADR and NA had no relevant actions on the parameters studied. On the basis of our findings, we conclude that the lipid metabolism of rainbow trout myotubes in culture is generally more sensitive to insulin family members and inhibitors than glucose metabolism, especially the oxidative processes. This conclusion is consistent with the high use of lipids as a major energy source in fish muscle, especially in salmonids.
Perspectives and Significance
Global aquaculture production has increased strongly in recent decades. One important objective in the development of this area is to maintain the benefits that the FA composition of fish flesh has for human consumption. This study revealed that the oleic acid and glucose metabolism in rainbow trout myotubes in culture are affected by hormonal treatment and by some drugs. This knowledge opens new possibilities for in vivo studies aimed at adjusting farmed fish composition. Knowing how the metabolism of FA and glucose in fish muscle is regulated may help us to improve flesh quality for consumption and also to facilitate the effectiveness of new dietary components.
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